Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 20: 184-187, 1974;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meola, J. M.
Right arrow Articles by Vanko, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meola, J. M.
Right arrow Articles by Vanko, M.

Clinical Chemistry, Vol 20, 184-187, Copyright © 1974 by the American Association for Clinical Chemistry

Use of Charcoal to Concentrate Drugs from Urine before Drug Analysis

John M. Meola 1 and Michael Vanko 1

1 Department of Clinical Chemistry, Albany Medical Center Hospital, Albany, N. Y. 12208.

A simple, efficient method is described for detecting various drugs in urine, such as barbiturates, glutethimide, ethchlorvynol, amphetamines, phenothiazines, quinine, morphine, cocaine and its metabolites, diazepam, chlordiazepoxide. The drugs are adsorbed from urine onto charcoal, selectively eluted with small amounts of ethyl ether or chloroform—isopropanol, separated and identified by thin-layer chromatography. Sequential spraying of the chromatographic plates with conventional reagents (except for fluorescamine, which is used to detect d-amphetamine) makes the drugs visible. The average detection limit for all drugs is 1.0 µg/ml of urine. The procedure is fast, economical, and adaptable to any urine screening program. No emulsions are formed and water washings are not required as with the use of resins. The preliminary charcoal-adsorption step permits excellent thin-layer chromatographic resolution of the drugs, with low background of interfering compounds.


Key Words: drug abuse • toxicology • thin-layer chromatography • preliminary sample purification • screening

Submitted on November 5, 1973
Accepted on November 20, 1973







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American Association for Clinical Chemistry.